Provision of sexual health and HIV services has become ‘fragmented’ in England since responsibility for commissioning was split across local authorities, clinical commissioning groups (CCGs) and NHS England, a survey by Public Health England has found.
Community pharmacies are ideally placed to be the first port of call for women requiring comprehensive and convenient contraceptive and sexual health services, concluded a discussion at the SalvaDore 2017 annual conference in Birmingham, UK.
A new class of antibiotic has been found to be effective against Neisseria gonorrhoeae according to researchers from Imperial College London and the London School of Hygiene and Tropical Medicine.
NHS England has announced the start of the trial to provide pre-exposure prophylaxis (PrEP) to people at high risk of HIV infection in England, in order to gather clinical evidence on optimal targeting, uptake and implementation of PrEP on a large scale.
Emergency contraception can be bought online in the UK for as little as £4.99.
Exposure to the meningococcal group B vaccine is associated with a reduced likelihood of contracting gonorrhoea, according to the findings of a large study in The Lancet.
More than half of women who had an abortion in 2016 were using at least one form of contraception when they presented, according to data gathered by the British Pregnancy Advisory Service (BPAS).
Cases of syphilis in England have reached the highest level since 1949, figures on sexually transmitted infections (STIs) for 2016 show.
US study shows that three doses of the Human Papillomavirus vaccine does not provide any more protection than two against genital warts.
Barriers, such as a price premium, should be removed to allow easier access to emergency hormonal contraception.
Allowing pharmacists to sell sildenafil would offer men a convenient, safe, and perhaps less intimidating, channel for seeking professional advice and treatment for erectile dysfunction.
The problem of dwindling treatment options for gonorrhoea is complicated because there are very few new antibiotics in development. Stewardship of our remaining antibiotic resources is now more urgent than ever.